CSF Testing for AIDP
Order CSF protein level and cell count as the essential tests for AIDP diagnosis 1.
Core CSF Tests Required
The classic CSF finding in AIDP is albuminocytologic dissociation - elevated protein with normal cell count 1. Specifically, you should order:
- CSF total protein - Typically elevated (mean ~1100 mg/L in AIDP patients) 2
- CSF cell count - Should remain normal or show only mild elevation (≤10 cells/μL is typical) 1, 2
These two tests form the diagnostic cornerstone. The combination of elevated protein with normal cell count occurs in approximately 94% of AIDP cases 2.
Additional Standard CSF Tests
Beyond the essential protein and cell count, order:
- CSF albumin - Helps quantify blood-brain barrier dysfunction 2
- CSF/serum albumin quotient - More specific marker of barrier disruption 2
- CSF IgG levels - Part of standard inflammatory workup 2
Important Timing Caveat
Early in the disease course, CSF findings may be completely normal 1. If you perform lumbar puncture within the first few days of symptom onset, protein elevation may not yet be present. This does not exclude AIDP. If clinical suspicion remains high with normal initial CSF, consider repeat testing after several days.
What NOT to Routinely Order
- Oligoclonal bands - These are typically absent in AIDP (found in only 0% of AIDP patients in one study) and are more associated with CIDP or CNS inflammation 2. Not useful for AIDP diagnosis.
Cell Count Red Flags
While mild pleocytosis can occur (up to 19% of AIDP patients may have slightly elevated cells) 2, cell counts >50 cells/μL should prompt consideration of alternative diagnoses such as Lyme disease, HIV-associated neuropathy, or lymphomatous meningitis 1.
Emerging Biomarkers (Not Yet Standard)
Recent research suggests potential value in measuring neuronal inflammation markers (NfL, NfH, GFAP, sphingomyelin, BDNF) 3, but these are investigational and not part of routine clinical practice. Standard protein and cell count remain the diagnostic workhorses.
Prognostic Value
Higher CSF protein levels at disease onset correlate with worse disability scores both initially and at one month 4. This information can help stratify patients for more aggressive monitoring and treatment.